Impact of Asthma on Severity and Outcomes in COVID-19

References

1. 1.↵
   1. Chidambaram V,
   2. Tun NL,
   3. Haque WZ,
   4. Majella MG,
   5. Sivakumar RK,
   6. Kumar A,
   7. et al

   . Factors associated with disease severity and mortality among patients with COVID-19: a systematic review and meta-analysis. PLoS One 2020;15(11):e0241541.

   OpenUrlCrossRef
2. 2.
   1. Dorjee K,
   2. Kim H,
   3. Bonomo E,
   4. Dolma R

   . Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: a comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients. PLoS One 2020;15(12):e0243191.

   OpenUrlCrossRefPubMed
3. 3.
   1. Figliozzi S,
   2. Masci PG,
   3. Ahmadi N,
   4. Tondi L,
   5. Koutli E,
   6. Aimo A,
   7. et al

   . Predictors of adverse prognosis in COVID-19: a systematic review and meta-analysis. Eur J Clin Invest 2020;50(10):e13362.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Javanmardi F,
   2. Keshavarzi A,
   3. Akbari A,
   4. Emami A,
   5. Pirbonyeh N

   . Prevalence of underlying diseases in died cases of COVID-19: a systematic review and meta-analysis. PLoS One 2020;15(10):e0241265.

   OpenUrl
5. 5.
   1. Mesas AE,
   2. Cavero-Redondo I,
   3. Alvarez-Bueno C,
   4. Sarria Cabrera MA,
   5. Maffei de Andrade S,
   6. Sequi-Dominguez I,
   7. et al

   . Predictors of in-hospital COVID-19 mortality: a comprehensive systematic review and meta-analysis exploring differences by age, sex, and health conditions. PLoS One 2020;15(11):e0241742.

   OpenUrlPubMed
6. 6.
   1. Silverio A,
   2. Di Maio M,
   3. Citro R,
   4. Esposito L,
   5. Iuliano G,
   6. Bellino M,
   7. et al

   . Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients. BMC Cardiovasc Disord 2021;21(1):23.

   OpenUrlPubMed
7. 7.↵
   1. Williamson EJ,
   2. Walker AJ,
   3. Bhaskaran K,
   4. Bacon S,
   5. Bates C,
   6. Morton CE,
   7. et al

   . Factors associated with COVID-19–related death using OpenSAFELY. Nature 2020;584(7821):430-436.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Yang J,
   2. Zheng Y,
   3. Gou X,
   4. Pu K,
   5. Chen Z,
   6. Guo Q,
   7. et al

   . Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis 2020;94:91-95.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Papadopoulos NG,
   2. Christodoulou I,
   3. Rohde G,
   4. Agache I,
   5. Almqvist C,
   6. Bruno A,
   7. et al

   . Viruses and bacteria in acute asthma exacerbations–a GA² LEN-DARE systematic review. Allergy 2011;66(4):458-468.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Mendes NF,
    2. Jara CP,
    3. Mansour E,
    4. Araújo EP,
    5. Velloso LA

    . Asthma and COVID-19: a systematic review. Allergy Asthma Clin Immunol 2021;17(1):5.

    OpenUrl
11. 11.↵
    1. Liu S,
    2. Cao Y,
    3. Du T,
    4. Zhi Y

    . Prevalence of comorbid asthma and related outcomes in COVID-19: a systematic review and meta-analysis. J Allergy Clin Immunol Pract 2021;9(2):693-701.

    OpenUrl
12. 12.
    1. Shi L,
    2. Xu J,
    3. Xiao W,
    4. Wang Y,
    5. Jin Y,
    6. Chen S,
    7. et al

    . Asthma in patients with coronavirus disease 2019: a systematic review and meta-analysis. Ann Allergy Asthma Immunol 2021;126(5):524-534.

    OpenUrl
13. 13.↵
    1. Skevaki C,
    2. Karsonova A,
    3. Karaulov A,
    4. Xie M,
    5. Renz H

    . Asthma-associated risk for COVID-19 development. J Allergy Clin Immunol 2020;146(6):1295-1301.

    OpenUrl
14. 14.↵
    1. Li P,
    2. Wang Y,
    3. Peppelenbosch MP,
    4. Ma Z,
    5. Pan Q

    . Systematically comparing COVID-19 with the 2009 influenza pandemic for hospitalized patients. Int J Infect Dis 2021;102:375-380.

    OpenUrl
15. 15.↵
    1. Mehraeen E,
    2. Karimi A,
    3. Barzegary A,
    4. Vahedi F,
    5. Afsahi AM,
    6. Dadras O,
    7. et al

    . Predictors of mortality in patients with COVID-19-a systematic review. Eur J Integr Med 2020;40:101226.

    OpenUrlPubMed
16. 16.↵
    1. Ssentongo P,
    2. Ssentongo AE,
    3. Heilbrunn ES,
    4. Ba DM,
    5. Chinchilli VM

    . Association of cardiovascular disease and 10 other preexisting comorbidities with COVID-19 mortality: A systematic review and meta-analysis. PLoS One 2020;15(8):e0238215.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Sunjaya AP,
    2. Allida SM,
    3. Tanna D,
    4. Jenkins GL

    . Asthma and risk of infection, hospitalization, ICU admission, and mortality from COVID-19: systematic review and meta-analysis. J Asthma 2021:1-22.
18. 18.
    1. Wang Y,
    2. Ao G,
    3. Qi X,
    4. Xie B

    . The association between COVID-19 and asthma: a systematic review and meta-analysis. Clin Exp Allergy 2020;50(11):1274-1277.

    OpenUrl
19. 19.
    1. Wang Y,
    2. Chen J,
    3. Chen W,
    4. Liu L,
    5. Dong M,
    6. Ji J,
    7. et al

    . Does asthma increase the mortality of patients with COVID-19?: a systematic review and meta-analysis. Int Arch Allergy Immunol 2021;182(1):76-82.

    OpenUrlPubMed
20. 20.↵
    1. Wang Y,
    2. Ao G,
    3. Qi X,
    4. Ma M

    . The relationship between severe or dead COVID-19 and asthma: a meta-analysis. Clin Exp Allergy 2021;51(2):354-359.

    OpenUrl
21. 21.↵
    1. Terry PD,
    2. Heidel RE,
    3. Dhand R

    . Asthma in adult patients with COVID-19: prevalence and risk of severe disease. Am J Respir Crit Care Med 2021;203(7):893-905.

    OpenUrl
22. 22.↵
    1. Rogliani P,
    2. Lauro D,
    3. Di Daniele N,
    4. Chetta A,
    5. Calzetta L

    . Reduced risk of COVID-19 hospitalization in asthmatic and COPD patients: a benefit of inhaled corticosteroids? Expert Rev Respir Med 2021;15(4):561-568.

    OpenUrlCrossRef
23. 23.↵
    1. Liberati A,
    2. Altman DG,
    3. Tetzlaff J,
    4. Mulrow C,
    5. Gotzsche PC,
    6. Ioannidis JP,
    7. et al

    . The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009;151(4):W65-94.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    1. Stroup DF,
    2. Berlin JA,
    3. Morton SC,
    4. Olkin I,
    5. Williamson GD,
    6. Rennie D,
    7. et al

    . Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 2000;283(15):2008-2012.

    OpenUrlCrossRefPubMedWeb of Science
25. 25.↵
    1. Morris JA,
    2. Gardner MJ

    . Calculating confidence intervals for relative risks (odds ratios) and standardized ratios and rates. Br Med J (Clin Res Ed) 1988;296(6632):1313-1316.

    OpenUrlFREE Full Text
26. 26.↵
    1. DerSimonian R,
    2. Laird N

    . Meta-analysis in clinical trials. Control Clin Trials 1986;7(3):177-188.

    OpenUrlCrossRefPubMedWeb of Science
27. 27.↵
    1. Higgins JP,
    2. Thompson SG,
    3. Deeks JJ,
    4. Altman DG

    . Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-560.

    OpenUrlFREE Full Text
28. 28.↵
    1. Egger M,
    2. Davey Smith G,
    3. Schneider M,
    4. Minder C

    . Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-634.

    OpenUrlAbstract/FREE Full Text
29. 29.↵
    1. Aggarwal A,
    2. Shrivastava A,
    3. Kumar A,
    4. Ali A

    . Clinical and epidemiological features of SARS-CoV-2 patients in SARI ward of a tertiary care center in New Delhi. J Assoc Physicians India 2020;68(7):19-26.

    OpenUrlPubMed
30. 30.↵
    1. Alizadehsani R,
    2. Alizadeh Sani Z,
    3. Behjati M,
    4. Roshanzamir Z,
    5. Hussain S,
    6. Abedini N,
    7. et al

    . Risk factors prediction, clinical outcomes, and mortality in COVID-19 patients. J Med Virol 2021;93(4):2307-2320.

    OpenUrl
31. 31.↵
    1. Almazeedi S,
    2. Al-Youha S,
    3. Jamal MH,
    4. Al-Haddad M,
    5. Al-Muhaini A,
    6. Al-Ghimlas F,
    7. et al

    . Characteristics, risk factors and outcomes among the first consecutive 1,096 patients diagnosed with COVID-19 in Kuwait. EClinicalMedicine 2020;24:100448.

    OpenUrlPubMed
32. 32.↵
    1. Andrikopoulou M,
    2. Madden N,
    3. Wen T,
    4. Aubey JJ,
    5. Aziz A,
    6. Baptiste CD,
    7. et al

    . Symptoms and critical illness among obstetric patients with coronavirus disease 2019 (COVID-19) infection. Obstet Gynecol 2020;136(2):291-299.

    OpenUrlCrossRefPubMed
33. 33.↵
    1. Argenziano MG,
    2. Bruce SL,
    3. Slater CL,
    4. Tiao JR,
    5. Baldwin MR,
    6. Barr RG,
    7. et al

    . Characterization and clinical course of 1,000 patients with coronavirus disease 2019 in New York: retrospective case series. BMJ 2020;369:m1996.

    OpenUrlAbstract/FREE Full Text
34. 34.↵
    1. Azar KMJ,
    2. Shen Z,
    3. Romanelli RJ,
    4. Lockhart SH,
    5. Smits K,
    6. Robinson S,
    7. et al

    . Disparities in outcomes among COVID-19 patients in a large health care system in California. Health Aff (Millwood) 2020;39(7):1253-1262.

    OpenUrlPubMed
35. 35.↵
    1. Baqui P,
    2. Bica I,
    3. Marra V,
    4. Ercole A,
    5. van der Schaar M

    . Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study. Lancet Glob Health 2020;8(8):e1018-e1026.

    OpenUrl
36. 36.
    1. Barroso B,
    2. Valverde-Monge M,
    3. Cañas Jose A,
    4. Rodrigo-Muñoz JM,
    5. Gonzalez-Cano B,
    6. Villalobos-Violan V,
    7. et al

    ; COVID-FJD TEAM. Prevalence, characteristics, and outcome of asthmatic patients with type 2 diseases in hospitalized patients with COVID-19 in Madrid, Spain. J Investig Allergol Clin Immunol 2020;30(5):382-384.

    OpenUrl
37. 37.↵
    1. Berenguer J,
    2. Ryan P,
    3. Rodríguez-Baño J,
    4. Jarrín I,
    5. Carratalà J,
    6. Pachón J,
    7. et al

    ; Centro Nacional de Epidemiología. Characteristics and predictors of death among 4,035 consecutively hospitalized patients with COVID-19 in Spain. Clin Microbiol Infect 2020;26(11):1525-1536.

    OpenUrlCrossRefPubMed
38. 38.↵
    1. Bermejo-Martin JF,
    2. González-Rivera M,
    3. Almansa R,
    4. Micheloud D,
    5. Tedim AP,
    6. Domínguez-Gil M,
    7. et al

    . Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19. Crit Care 2020;24(1):691.

    OpenUrlCrossRef
39. 39.↵
    1. Beurnier A,
    2. Jutant EM,
    3. Jevnikar M,
    4. Boucly A,
    5. Pichon J,
    6. Preda M,
    7. et al

    . Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalization. Eur Respir J 2020;56(5):2001875.

    OpenUrlAbstract/FREE Full Text
40. 40.
    1. Borobia AM,
    2. Carcas AJ,
    3. Arnalich F,
    4. Alvarez-Sala R,
    5. Monserrat-Villatoro J,
    6. Quintana M,
    7. et al

    . A cohort of patients with COVID-19 in a major teaching hospital in Europe. J Clin Med 2020;9(6):1733.

    OpenUrl
41. 41.↵
    1. Broadhurst R,
    2. Peterson R,
    3. Wisnivesky JP,
    4. Federman A,
    5. Zimmer SM,
    6. Sharma S,
    7. et al

    . Asthma in COVID-19 hospitalizations: an overestimated risk factor? Ann Am Thorac Soc 2020;17(12):1645-1648.

    OpenUrl
42. 42.
    1. Buckner FS,
    2. McCulloch DJ,
    3. Atluri V,
    4. Blain M,
    5. McGuffin SA,
    6. Nalla AK,
    7. et al

    . Clinical features and outcomes of 105 hospitalized patients with COVID-19 in Seattle, Washington. Clin Infect Dis 2020;71(16):2167-2173.

    OpenUrl
43. 43.↵
    1. Calderon JAL,
    2. Martin PB,
    3. Rodriguez RG,
    4. Cataldi HSC,
    5. Sánchez CJS

    . Differentiating characteristics of patients with asthma in the severe acute respiratory syndrome coronavirus 2 infection. Ann Allergy Asthma Immunol 2021;126(1):92-93.

    OpenUrl
44. 44.↵
    1. Caliskan T,
    2. Saylan B

    . Smoking and comorbidities are associated with COVID-19 severity and mortality in 565 patients treated in Turkey: a retrospective observational study. Rev Assoc Med Bras (Bras 2020;66(12):1679-1684.

    OpenUrl
45. 45.↵
    1. Calmes D,
    2. Graff S,
    3. Maes N,
    4. Frix AN,
    5. Thys M,
    6. Bonhomme O,
    7. et al

    . Asthma and COPD are not risk factors for ICU stay and death in case of SARS-CoV2 infection. J Allergy Clin Immunol Pract 2021;9(1):160-169.

    OpenUrl
46. 46.↵
    1. Chao JY,
    2. Derespina KR,
    3. Herold BC,
    4. Goldman DL,
    5. Aldrich M,
    6. Weingarten J,
    7. et al

    . Clinical characteristics and outcomes of hospitalized and critically ill children and adolescents with coronavirus disease 2019 at a tertiary care medical center in New York city. J Pediatr 2020;223:14-19.

    OpenUrlCrossRefPubMed
47. 47.↵
    1. Chen R,
    2. Sang L,
    3. Jiang M,
    4. Yang Z,
    5. Jia N,
    6. Fu W,
    7. et al

    ; Medical Treatment Expert Group for COVID-19. Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J Allergy Clin Immunol 2020;146(1):89-100.

    OpenUrlPubMed
48. 48.↵
    1. Chhiba KD,
    2. Patel GB,
    3. Vu THT,
    4. Chen MM,
    5. Guo A,
    6. Kudlaty E,
    7. et al

    . Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19. J Allergy Clin Immunol 2020;146(2):307-314.

    OpenUrlPubMed
49. 49.↵
    1. Choi YJ,
    2. Park JY,
    3. Lee HS,
    4. Suh J,
    5. Song JY,
    6. Byun MK,
    7. et al

    . Effect of asthma and asthma medication on the prognosis of patients with COVID-19. Eur Respir J 2021;57(3):2002226.

    OpenUrlAbstract/FREE Full Text
50. 50.
    1. Corsini Campioli C,
    2. Cano Cevallos E,
    3. Assi M,
    4. Patel R,
    5. Binnicker MJ,
    6. O'Horo JC

    . Clinical predictors and timing of cessation of viral RNA shedding in patients with COVID-19. J Clin Virol 2020;130:104577.

    OpenUrlPubMed
51. 51.↵
    1. Docherty AB,
    2. Harrison EM,
    3. Green CA,
    4. Hardwick HE,
    5. Pius R,
    6. Norman L,
    7. et al

    ; ISARIC4C investigators. Features of 20,133 UK patients in hospital with COVID-19 using the ISARIC WHO clinical characterization protocol: prospective observational cohort study. BMJ 2020;369:m1985.

    OpenUrlAbstract/FREE Full Text
52. 52.
    1. Duanmu Y,
    2. Brown IP,
    3. Gibb WR,
    4. Singh J,
    5. Matheson LW,
    6. Blomkalns AL,
    7. et al

    . Characteristics of emergency department patients with COVID-19 at a single site in northern California: clinical observations and public health implications. Acad Emerg Med 2020;27(6):505-509.

    OpenUrl
53. 53.↵
    1. Garcia-Pachon E,
    2. Zamora-Molina L,
    3. Soler-Sempere MJ,
    4. Baeza-Martinez C,
    5. Grau-Delgado J,
    6. Canto-Reig V,
    7. et al

    . Asthma prevalence in patients with SARS-CoV-2 infection detected by RT-PCR not requiring hospitalization. Respir Med 2020;171:106084.

    OpenUrl
54. 54.↵
    1. Garibaldi BT,
    2. Fiksel J,
    3. Muschelli J,
    4. Robinson ML,
    5. Rouhizadeh M,
    6. Perin J,
    7. et al

    . Patient trajectories among persons hospitalized for COVID-19: a cohort study. Ann Intern Med 2021;174(1):33-41.

    OpenUrlPubMed
55. 55.
    1. Gayam V,
    2. Chobufo MD,
    3. Merghani MA,
    4. Lamichhane S,
    5. Garlapati PR,
    6. Adler MK

    . Clinical characteristics and predictors of mortality in African Americans with COVID-19 from an inner-city community teaching hospital in New York. J Med Virol 2021;93(2):812-819.

    OpenUrlPubMed
56. 56.↵
    1. Georges JL,
    2. Cochet H,
    3. Roger G,
    4. Ben Jemaa H,
    5. Soltani J,
    6. Azowa JB,
    7. et al

    . Association of hypertension and antihypertensive agents and the severity of COVID-19 pneumonia. A monocentric French prospective study. Ann Cardiol Angeiol (Paris) 2020;69(5):247-254.

    OpenUrl
57. 57.
    1. Gottlieb M,
    2. Sansom S,
    3. Frankenberger C,
    4. Ward E,
    5. Hota B

    . Clinical course and factors associated with hospitalization and critical illness among COVID-19 patients in Chicago, Illinois. Acad Emerg Med 2020;27(10):963-973.

    OpenUrlPubMed
58. 58.
    1. Goyal P,
    2. Choi JJ,
    3. Pinheiro LC,
    4. Schenck EJ,
    5. Chen R,
    6. Jabri A,
    7. et al

    . Clinical characteristics of COVID-19 in New York City. N Engl J Med 2020;382(24):2372-2374.

    OpenUrlPubMed
59. 59.↵
    1. Green I,
    2. Merzon E,
    3. Vinker S,
    4. Golan-Cohen A,
    5. Magen E

    . COVID-19 susceptibility in bronchial asthma. J Allergy Clin Immunol Pract 2021;9(2):684-692.

    OpenUrl
60. 60.
    1. Gregoriano C,
    2. Koch D,
    3. Haubitz S,
    4. Conen A,
    5. Fux CA,
    6. Mueller B,
    7. et al

    . Characteristics, predictors and outcomes among 99 patients hospitalized with COVID-19 in a tertiary care center in Switzerland: an observational analysis. Swiss Med Wkly 2020;150:w20316.

    OpenUrlCrossRef
61. 61.↵
    1. Gude-Sampedro F,
    2. Fernandez-Merino C,
    3. Ferreiro L,
    4. Lado-Baleato O,
    5. Espasandin-Dominguez J,
    6. Hervada X,
    7. et al

    . Development and validation of a prognostic model based on comorbidities to predict COVID-19 severity. a population-based study. Int J Epidemiol 2021;50(1):64-74.

    OpenUrl
62. 62.
    1. Gunal O,
    2. Ture E,
    3. Bayburtlu M,
    4. Arslan U,
    5. Demirag MD,
    6. Taskin MH,
    7. et al

    . Evaluation of patients diagnosed with COVID-19 in terms of risk factors. Mikrobiyol Bul 2020;54(4):575-582.

    OpenUrl
63. 63.↵
    1. Gupta S,
    2. Hayek SS,
    3. Wang W,
    4. Chan L,
    5. Mathews KS,
    6. Melamed ML,
    7. et al

    ; STOP-COVID Investigators. Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA Intern Med 2020;180(11):1436-1447.

    OpenUrl
64. 64.
    1. Halvatsiotis P,
    2. Kotanidou A,
    3. Tzannis K,
    4. Jahaj E,
    5. Magira E,
    6. Theodorakopoulou M,
    7. et al

    . Demographic and clinical features of critically ill patients with COVID-19 in Greece: the burden of diabetes and obesity. Diabetes Res Clin Pract 2020;166:108331.

    OpenUrl
65. 65.
    1. Hashmi MD,
    2. Alnababteh M,
    3. Vedantam K,
    4. Alunikummannil J,
    5. Oweis ES,
    6. Shorr AF

    . Assessing the need for transfer to the intensive care unit for coronavirus-19 disease: epidemiology and risk factors. Respir Med 2020;174:106203.

    OpenUrlCrossRefPubMed
66. 66.
    1. Haw NJL,
    2. Uy J,
    3. Sy KTL,
    4. Abrigo MRM

    . Epidemiological profile and transmission dynamics of COVID-19 in the Philippines. Epidemiol Infect 2020;148:e204.

    OpenUrl
67. 67.↵
    1. Hernandez-Galdamez DR,
    2. Gonzalez-Block MA,
    3. Romo-Duenas DK,
    4. Lima-Morales R,
    5. Hernandez-Vicente IA,
    6. Lumbreras-Guzman M,
    7. et al

    . Increased risk of hospitalization and death in patients with COVID-19 and preexisting noncommunicable diseases and modifiable risk factors in Mexico. Arch Med Res 2020;51(7):683-689.

    OpenUrlCrossRefPubMed
68. 68.↵
    1. Hsu HE,
    2. Ashe EM,
    3. Silverstein M,
    4. Hofman M,
    5. Lange SJ,
    6. Razzaghi H,
    7. et al

    . Race/ethnicity, underlying medical conditions, homelessness, and hospitalization status of adult patients with COVID-19 at an urban safety-net medical center - Boston, Massachusetts, 2020. MMWR Morb Mortal Wkly Rep 2020;69(27):864-869.

    OpenUrl
69. 69.
    1. Huang H,
    2. Song B,
    3. Xu Z,
    4. Jiao Y,
    5. Huang L,
    6. Zhao P,
    7. et al

    . Predictors of coronavirus disease 2019 severity: a retrospective study of 64 cases. Jpn J Infect Dis 2021;74(1):54-60.

    OpenUrlCrossRefPubMed
70. 70.↵
    1. Hussein MH,
    2. Toraih EA,
    3. Attia AS,
    4. Burley N,
    5. Zhang AD,
    6. Roos J,
    7. et al

    . Asthma in COVID-19 patients: an extra chain fitting around the neck? Respir Med 2020;175:106205.

    OpenUrl
71. 71.↵
    1. Ioannou GN,
    2. Locke E,
    3. Green P,
    4. Berry K,
    5. O’Hare AM,
    6. Shah JA,
    7. et al

    . Risk factors for hospitalization, mechanical ventilation, or death among 10,131 US veterans with SARS-CoV-2 infection. JAMA Netw Open 2020;3(9):e2022310.

    OpenUrl
72. 72.↵
    1. Israelsen SB,
    2. Kristiansen KT,
    3. Hindsberger B,
    4. Ulrik CS,
    5. Andersen O,
    6. Jensen M,
    7. et al

    . Characteristics of patients with COVID-19 pneumonia at Hvidovre Hospital, March-April 2020. Dan Med J 2020;67(6):A05200313.

    OpenUrlPubMed
73. 73.
    1. Jehi L,
    2. Ji X,
    3. Milinovich A,
    4. Erzurum S,
    5. Merlino A,
    6. Gordon S,
    7. et al

    . Development and validation of a model for individualized prediction of hospitalization risk in 4,536 patients with COVID-19. PLoS One 2020;15(8):e0237419.

    OpenUrlPubMed
74. 74.
    1. Jimenez E,
    2. Fontan-Vela M,
    3. Valencia J,
    4. Fernandez-Jimenez I,
    5. Alvaro-Alonso EA,
    6. Izquierdo-Garcia E,
    7. et al

    ; [email protected] Working Group. Characteristics, complications and outcomes among 1,549 patients hospitalized with COVID-19 in a secondary hospital in Madrid, Spain: a retrospective case series study. BMJ Open 2020;10(11):e042398.

    OpenUrlAbstract/FREE Full Text
75. 75.↵
    1. Khalil K,
    2. Agbontaen K,
    3. McNally D,
    4. Love A,
    5. Mandalia S,
    6. Banya W,
    7. et al

    . Clinical characteristics and 28-day mortality of medical patients admitted with COVID-19 to a central London teaching hospital. J Infect 2020;81(3):e85-e89.

    OpenUrlCrossRef
76. 76.↵
    1. Kim S,
    2. Jung CG,
    3. Lee JY,
    4. Kim G,
    5. Choi SW,
    6. Jin HJ,
    7. et al

    . Characterization of asthma and risk factors for delayed SARS-CoV-2 clearance in adult COVID-19 inpatients in Daegu. Allergy 2021;76(3):918-921.

    OpenUrl
77. 77.↵
    1. Lee JY,
    2. Hong SW,
    3. Hyun M,
    4. Park JS,
    5. Lee JH,
    6. Suh YS,
    7. et al

    . Epidemiological and clinical characteristics of coronavirus disease 2019 in Daegu, South Korea. Int J Infect Dis 2020;98:462-466.

    OpenUrlCrossRef
78. 78.↵
    1. Lieberman-Cribbin W,
    2. Rapp J,
    3. Alpert N,
    4. Tuminello S,
    5. Taioli E

    . The impact of asthma on mortality in patients with COVID-19. Chest 2020;158(6):2290-2291.

    OpenUrl
79. 79.
    1. Lombardi C,
    2. Roca E,
    3. Bigni B,
    4. Cottini M,
    5. Passalacqua G

    . Clinical course and outcomes of patients with asthma hospitalized for severe acute respiratory syndrome coronavirus 2 pneumonia: a single-center, retrospective study. Ann Allergy Asthma Immunol 2020;125(6):707-709.

    OpenUrl
80. 80.
    1. Lovinsky-Desir S,
    2. Deshpande DR,
    3. De A,
    4. Murray L,
    5. Stingone JA,
    6. Chan A,
    7. et al

    . Asthma among hospitalized patients with COVID-19 and related outcomes. J Allergy Clin Immunol 2020;146(5):1027-1034.

    OpenUrl
81. 81.↵
    1. Ludwig M,
    2. Jacob J,
    3. Basedow F,
    4. Andersohn F,
    5. Walker J

    . Clinical outcomes and characteristics of patients hospitalized for Influenza or COVID-19 in Germany. Int J Infect Dis 2021;103:316-322.

    OpenUrl
82. 82.
    1. Maeda T,
    2. Obata R,
    3. Rizk DD,
    4. Kuno T

    . The association of interleukin-6 value, interleukin inhibitors, and outcomes of patients with COVID-19 in New York City. J Med Virol 2021;93(1):463-471.

    OpenUrlPubMed
83. 83.
    1. Mahdavinia M,
    2. Foster KJ,
    3. Jauregui E,
    4. Moore D,
    5. Adnan D,
    6. Andy-Nweye AB,
    7. et al

    . Asthma prolongs intubation in COVID-19. J Allergy Clin Immunol Pract 2020;8(7):2388-2391.

    OpenUrl
84. 84.
    1. Mani VR,
    2. Kalabin A,
    3. Valdivieso SC,
    4. Murray-Ramcharan M,
    5. Donaldson B

    . New York inner-city hospital COVID-19 experience and current data: retrospective analysis at the epicenter of the American coronavirus outbreak. J Med Internet Res 2020;22(9):e20548.

    OpenUrl
85. 85.
    1. Marcello RK,
    2. Dolle J,
    3. Grami S,
    4. Adule R,
    5. Li Z,
    6. Tatem K,
    7. et al

    ; New York City Health + Hospitals COVID-19 Population Health Data Team. Characteristics and outcomes of COVID-19 patients in New York City's public hospital system. PLoS One 2020;15(12):e0243027.

    OpenUrlPubMed
86. 86.↵
    1. Mikami T,
    2. Miyashita H,
    3. Yamada T,
    4. Harrington M,
    5. Steinberg D,
    6. Dunn A,
    7. et al

    . Risk factors for mortality in patients with COVID-19 in New York City. J Gen Intern Med 2021;36(1):17-26.

    OpenUrlPubMed
87. 87.
    1. Monteiro AC,
    2. Suri R,
    3. Emeruwa IO,
    4. Stretch RJ,
    5. Cortes-Lopez RY,
    6. Sherman A,
    7. et al

    . Obesity and smoking as risk factors for invasive mechanical ventilation in COVID-19: a retrospective, observational cohort study. PLoS One 2020;15(12):e0238552.

    OpenUrl
88. 88.
    1. Morrison AR,
    2. Johnson JM,
    3. Griebe KM,
    4. Jones MC,
    5. Stine JJ,
    6. Hencken LN,
    7. et al

    . Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab. J Autoimmun 2020;114:102512.

    OpenUrl
89. 89.↵
    1. Myrstad M,
    2. Ihle-Hansen H,
    3. Tveita AA,
    4. Andersen EL,
    5. Nygard S,
    6. Tveit A,
    7. et al

    . National early warning score 2 (NEWS2) on admission predicts severe disease and in-hospital mortality from COVID-19 - a prospective cohort study. Scand J Trauma Resusc Emerg Med 2020;28(1):66.

    OpenUrlCrossRefPubMed
90. 90.↵
    1. Nogueira PJ,
    2. de Araujo Nobre M,
    3. Costa A,
    4. Ribeiro RM,
    5. Furtado C,
    6. Bacelar Nicolau L,
    7. et al

    . The role of health preconditions on COVID-19 deaths in Portugal: evidence from surveillance data of the first 20,293 infection cases. J Clin Med 2020;9(8):1-16.

    OpenUrl
91. 91.
    1. O'Keefe JB,
    2. Tong EJ,
    3. Taylor TH Jr.,
    4. O'Keefe GAD,
    5. Tong DC

    . Use of a telemedicine risk assessment tool to predict the risk of hospitalization of 496 outpatients with COVID-19: retrospective analysis. JMIR Public Health Surveill 2021;7(4):e25075.

    OpenUrl
92. 92.↵
    1. Ortiz-Brizuela E,
    2. Villanueva-Reza M,
    3. Gonzalez-Lara MF,
    4. Tamez-Torres KM,
    5. Roman-Montes CM,
    6. Diaz-Mejia BA,
    7. et al

    . Clinical and epidemiological characteristics of patients diagnosed with COVID-19 in a tertiary care center in Mexico City: a prospective cohort study. Rev Invest Clin 2020;72(3):165-177.

    OpenUrlCrossRefPubMed
93. 93.↵
    1. Parra-Bracamonte GM,
    2. Lopez-Villalobos N,
    3. Parra-Bracamonte FE

    . Clinical characteristics and risk factors for mortality of patients with COVID-19 in a large data set from Mexico. Ann Epidemiol 2020;52:93-98.e92.

    OpenUrlPubMed
94. 94.
    1. Regina J,
    2. Papadimitriou-Olivgeris M,
    3. Burger R,
    4. Le Pogam MA,
    5. Niemi T,
    6. Filippidis P,
    7. et al

    . Epidemiology, risk factors, and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: an observational retrospective study. PLoS One 2020;15(11):e0240781.

    OpenUrl
95. 95.↵
    1. Riou M,
    2. Marcot C,
    3. Canuet M,
    4. Renaud-Picard B,
    5. Chatron E,
    6. Porzio M,
    7. et al

    . Clinical characteristics of and outcomes for patients with COVID-19 and comorbid lung diseases primarily hospitalized in a conventional pulmonology unit: a retrospective study. Respir Med Res 2021;79(100801).
96. 96.↵
    1. Robinson LB,
    2. Fu X,
    3. Bassett IV,
    4. Triant VA,
    5. Foulkes AS,
    6. Zhang Y,
    7. et al

    . COVID-19 severity in hospitalized patients with asthma: a matched cohort study. J Allergy Clin Immunol Pract 2021;9(1):497-500.

    OpenUrl
97. 97.
    1. Rosenthal JA,
    2. Awan SF,
    3. Fintzi J,
    4. Keswani A,
    5. Ein D

    . Asthma is associated with increased risk of intubation but not hospitalization or death in coronavirus disease 2019. Ann Allergy Asthma Immunol 2021;126(1):93-95.

    OpenUrl
98. 98.↵
    1. Salacup G,
    2. Lo KB,
    3. Gul F,
    4. Peterson E,
    5. De Joy R,
    6. Bhargav R,
    7. et al

    . Characteristics and clinical outcomes of COVID-19 patients in an underserved inner-city population: a single tertiary center cohort. J Med Virol 2021;93(1):416-423.

    OpenUrlCrossRefPubMed
99. 99.
    1. Sapey E,
    2. Gallier S,
    3. Mainey C,
    4. Nightingale P,
    5. McNulty D,
    6. Crothers H,
    7. et al

    ; all clinicians and students at University Hospitals Birmingham NHS Foundation Trust. Ethnicity and risk of death in patients hospitalized for COVID-19 infection in the UK: an observational cohort study in an urban catchment area. BMJ Open Respir Res 2020;7(1):e000644.

    OpenUrlAbstract/FREE Full Text
100. 100.
     1. Satici C,
     2. Demirkol MA,
     3. Sargin Altunok E,
     4. Gursoy B,
     5. Alkan M,
     6. Kamat S,
     7. et al

     . Performance of pneumonia severity index and CURB-65 in predicting 30-day mortality in patients with COVID-19. Int J Infect Dis 2020;98:84-89.

     OpenUrlCrossRefPubMed
101. 101.
     1. Shabrawishi M,
     2. Al-Gethamy MM,
     3. Naser AY,
     4. Ghazawi MA,
     5. Alsharif GF,
     6. Obaid EF,
     7. et al

     . Clinical, radiological, and therapeutic characteristics of patients with COVID-19 in Saudi Arabia. PLoS One 2020;15(8):e0237130.

     OpenUrlCrossRefPubMed
102. 102.
     1. Shahriarirad R,
     2. Khodamoradi Z,
     3. Erfani A,
     4. Hosseinpour H,
     5. Ranjbar K,
     6. Emami Y,
     7. et al

     . Epidemiological and clinical features of 2019 novel coronavirus diseases (COVID-19) in the south of Iran. BMC Infect Dis 2020;20(1):427.

     OpenUrlPubMed
103. 103.
     1. Singer AJ,
     2. Morley EJ,
     3. Meyers K,
     4. Fernandes R,
     5. Rowe AL,
     6. Viccellio P,
     7. et al

     . Cohort of 40,404 persons under investigation for COVID-19 in a New York hospital and predictors of ICU care and ventilation. Ann Emerg Med 2020;76(4):394-404.

     OpenUrlCrossRefPubMed
104. 104.↵
     1. Siso-Almirall A,
     2. Kostov B,
     3. Mas-Heredia M,
     4. Vilanova-Rotllan S,
     5. Sequeira-Aymar E,
     6. Sans-Corrales M,
     7. et al

     . Prognostic factors in Spanish COVID-19 patients: a case series from Barcelona. PLoS One 2020;15(8):e0237960.

     OpenUrl
105. 105.
     1. Smith AA,
     2. Fridling J,
     3. Ibrahim D,
     4. Porter PS

     Jr. Identifying patients at greatest risk of mortality due to COVID-19: a New England perspective. West J Emerg Med 2020;21(4):785-789.

     OpenUrlCrossRefPubMed
106. 106.
     1. Song J,
     2. Zeng M,
     3. Wang H,
     4. Qin C,
     5. Hou HY,
     6. Sun ZY,
     7. et al

     . Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID-19. Allergy 2021;76(2):483-496.

     OpenUrl
107. 107.
     1. Suleyman G,
     2. Fadel RA,
     3. Malette KM,
     4. Hammond C,
     5. Abdulla H,
     6. Entz A,
     7. et al

     . Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in metropolitan Detroit. JAMA Netw Open 2020;3(6):e2012270.

     OpenUrl
108. 108.
     1. Tartof SY,
     2. Qian L,
     3. Hong V,
     4. Wei R,
     5. Nadjafi RF,
     6. Fischer H,
     7. et al

     . Obesity and mortality among patients diagnosed with COVID-19: results from an integrated health care organization. Ann Intern Med 2020;173(10):773-781.

     OpenUrlCrossRefPubMed
109. 109.↵
     1. Tenforde MW,
     2. Billig Rose E,
     3. Lindsell CJ,
     4. Shapiro NI,
     5. Files DC,
     6. Gibbs KW,
     7. et al

     ; CDC COVID-19 Response Team. Characteristics of adult out-patients and in-patients with COVID-19 - 11 academic medical centers, United States, March-May 2020. MMWR Morb Mortal Wkly Rep 2020;69(26):841-846.

     OpenUrlCrossRefPubMed
110. 110.
     1. Thompson JV,
     2. Meghani NJ,
     3. Powell BM,
     4. Newell I,
     5. Craven R,
     6. Skilton G,
     7. et al

     . Patient characteristics and predictors of mortality in 470 adults admitted to a district general hospital in England with COVID-19. Epidemiol Infect 2020;148:e285.

     OpenUrlCrossRefPubMed
111. 111.↵
     1. Tomlins J,
     2. Hamilton F,
     3. Gunning S,
     4. Sheehy C,
     5. Moran E,
     6. MacGowan A

     . Clinical features of 95 sequential hospitalized patients with novel coronavirus 2019 disease (COVID-19), the first UK cohort. J Infect 2020;81(2):e59-e61.

     OpenUrlPubMed
112. 112.↵
     1. Trabulus S,
     2. Karaca C,
     3. Balkan II,
     4. Dincer MT,
     5. Murt A,
     6. Ozcan SG,
     7. et al

     . Kidney function on admission predicts in-hospital mortality in COVID-19. PLoS One 2020;15(9):e0238680.

     OpenUrlPubMed
113. 113.
     1. Uchida Y,
     2. Uemura H,
     3. Yamaba S,
     4. Hamada D,
     5. Tarumoto N,
     6. Maesaki S,
     7. et al

     . Significance of liver dysfunction associated with decreased hepatic CT attenuation values in Japanese patients with severe COVID-19. J Gastroenterol 2020;55(11):1098-1106.

     OpenUrlCrossRef
114. 114.
     1. Wang J,
     2. Guo S,
     3. Zhang Y,
     4. Gao K,
     5. Zuo J,
     6. Tan N,
     7. et al

     . Clinical features and risk factors for severe inpatients with COVID-19: a retrospective study in China. PLoS One 2020;15(12):e0244125.

     OpenUrl
115. 115.↵
     1. Yan CH,
     2. Faraji F,
     3. Prajapati DP,
     4. Ostrander BT,
     5. DeConde AS

     . Self-reported olfactory loss associates with outpatient clinical course in COVID-19. Int Forum Allergy Rhinol 2020;10(7):821-831.

     OpenUrlCrossRefPubMed
116. 116.↵
     1. Yang JM,
     2. Koh HY,
     3. Moon SY,
     4. Yoo IK,
     5. Ha EK,
     6. You S,
     7. et al

     . Allergic disorders and susceptibility to and severity of COVID-19: a nationwide cohort study. J Allergy Clin Immunol 2020;146(4):790-798.

     OpenUrlCrossRefPubMed
117. 117.↵
     1. Zhang JJ,
     2. Cao YY,
     3. Tan G,
     4. Dong X,
     5. Wang BC,
     6. Lin J,
     7. et al

     . Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients. Allergy 2021;76(2):533-550.

     OpenUrlPubMed
118. 118.↵
     1. Zhao Z,
     2. Chen A,
     3. Hou W,
     4. Graham JM,
     5. Li H,
     6. Richman PS,
     7. et al

     . Prediction model and risk scores of ICU admission and mortality in COVID-19. PLoS One 2020;15(7):e0236618.

     OpenUrlPubMed
119. 119.↵
     1. Pranata R,
     2. Soeroto AY,
     3. Huang I,
     4. Lim MA,
     5. Santoso P,
     6. Permana H,
     7. et al

     . Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-19. Int J Tuberc Lung Dis 2020;24(8):838-843.

     OpenUrl
120. 120.↵
     1. Rabbani G,
     2. Shariful Islam SM,
     3. Rahman MA,
     4. Amin N,
     5. Marzan B,
     6. Robin RC,
     7. et al

     . Preexisting COPD is associated with an increased risk of mortality and severity in COVID-19: a rapid systematic review and meta-analysis. Expert Rev Respir Med 2021;15(5):705-712.

     OpenUrlPubMed
121. 121.↵
     1. Jackson DJ,
     2. Busse WW,
     3. Bacharier LB,
     4. Kattan M,
     5. O'Connor GT,
     6. Wood RA,
     7. et al

     . Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE-2. J Allergy Clin Immunol 2020;146(1):203-206.

     OpenUrlPubMed
122. 122.↵
     1. Matsuyama S,
     2. Kawase M,
     3. Nao N,
     4. Shirato K,
     5. Ujike M,
     6. Kamitani W,
     7. et al

     . The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells. J Virol 2020;95(1):e01648-20.

     OpenUrl
123. 123.↵
     1. Peters MC,
     2. Sajuthi S,
     3. Deford P,
     4. Christenson S,
     5. Rios CL,
     6. Montgomery MT,
     7. et al

     . COVID-19–related genes in sputum cells in asthma. Relationship to demographic features and corticosteroids. Am J Respir Crit Care Med 2020;202(1):83-90.

     OpenUrl
124. 124.↵
     1. Baraniuk C

     . COVID-19: People with mild asthma won't get early vaccination. BMJ 2021;372:n430.

     OpenUrlFREE Full Text